• By: Yuka Osada
• On: November 12, 2026

Live Biotherapeutic Products: U.S. Regulatory Evolution, Trends, and Lessons

• By: Yuka Osada
• On: January 22, 2026

Eye on the Horizon: The $79B Evolution of Ophthalmic Therapies